Evaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP Challenge

NCT06805487 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

NIH

Sponsor class

Conditions

Zika Virus

Interventions

BIOLOGICAL: TetraVax-DV-TV003 (TV003)
BIOLOGICAL: Plasmalyte
BIOLOGICAL: Challenge virus ZIKV-SJRP/2016-184

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]